References
  1. Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations. World J Nephrol . 2013; 2(3): 56-76.
  2. Hartland EL, Leong JM. Enteropathogenic and enterohemorrhagic E. coli : ecology, pathogenesis and evolution. Front Microbio . 2013; 3:15.
  3. Kouzy R, Alawieh R, Sukhon F, Temraz S. A case of typical hemolytic uremic syndrome in an adult. Cureus . 2018; 10(9): e3289.
  4. Chinchilla-Lopez P, Cruz-Ramon V, Ramirez-Perez O, Mendez-Sanchez N. Gastroenteritis in an adult female revealing hemolytic uremic syndrome: case report. World J Gastroenterol . 2018; 24(6):763-766.
  5. Hu J, Torres AG. Enteropathogenic E. coli : foe or innocent bystander? Clin Microbiol Infect . 2015; 21(8): 729-734.
  6. Nguyen Y, Sperandio V. Enterohemorrhagic E. coli pathogenesis.Front Cell Infect Microbiol . 2012; 2:90.
  7. Yau JW, Teoh H, Verma S. Endothelial cell control of thrombosis.BMC Cardiovasc Disord . 2015; 15:30.
  8. Nester CM, Thomas CP. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated? Hematology . 2012(1); 617-625.
  9. Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol . 2012; 8:622-633.